Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.

Goupil M, Cousineau-Côté V, Aumont F, Sénéchal S, Gaboury L, Hanna Z, Jolicoeur P, de Repentigny L.

BMC Immunol. 2014 Oct 26;15:49. doi: 10.1186/s12865-014-0049-9.

2.

Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Leongson K, Cousineau-Côté V, Goupil M, Aumont F, Sénéchal S, Gaboury L, Jolicoeur P, Kronstad JW, de Repentigny L.

Infect Immun. 2013 Apr;81(4):1100-13. doi: 10.1128/IAI.01339-12. Epub 2013 Jan 22.

3.

Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Goupil M, Trudelle EB, Dugas V, Racicot-Bergeron C, Aumont F, Sénéchal S, Hanna Z, Jolicoeur P, de Repentigny L.

Infect Immun. 2009 Sep;77(9):4136-49. doi: 10.1128/IAI.00453-09. Epub 2009 Jun 29.

4.

Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1.

de Repentigny L, Lewandowski D, Aumont F, Hanna Z, Jolicoeur P.

Methods Mol Biol. 2009;470:359-68. doi: 10.1007/978-1-59745-204-5_25.

PMID:
19089395
5.

Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.

Lewandowski D, Marquis M, Aumont F, Lussier-Morin AC, Raymond M, Sénéchal S, Hanna Z, Jolicoeur P, de Repentigny L.

J Immunol. 2006 Jul 1;177(1):479-91.

6.

CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.

Marquis M, Lewandowski D, Dugas V, Aumont F, Sénéchal S, Jolicoeur P, Hanna Z, de Repentigny L.

Infect Immun. 2006 Apr;74(4):2382-91.

7.

A simple fall in the elderly: not so simple.

Bergeron E, Clement J, Lavoie A, Ratte S, Bamvita JM, Aumont F, Clas D.

J Trauma. 2006 Feb;60(2):268-73.

PMID:
16508481
8.

Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro.

Ripeau JS, Aumont F, Belhumeur P, Ostrosky-Zeichner L, Rex JH, de Repentigny L.

Antimicrob Agents Chemother. 2002 Sep;46(9):3096-100.

9.

Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1.

de Repentigny L, Aumont F, Ripeau JS, Fiorillo M, Kay DG, Hanna Z, Jolicoeur P.

J Infect Dis. 2002 Apr 15;185(8):1103-14. Epub 2002 Mar 21.

PMID:
11930320
10.

Evidence for differential expression of candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice.

Ripeau JS, Fiorillo M, Aumont F, Belhumeur P, de Repentigny L.

J Infect Dis. 2002 Apr 15;185(8):1094-102. Epub 2002 Mar 21.

PMID:
11930319
11.
12.

Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice.

Dubois N, Colina AR, Aumont F, Belhumeur P, de Repentigny L.

Microbiology. 1998 Aug;144 ( Pt 8):2299-310.

PMID:
9720053
13.

Development of a method to detect secretory mucinolytic activity from Candida albicans.

Colina AR, Aumont F, Belhumeur P, de Repentigny L.

J Med Vet Mycol. 1996 Nov-Dec;34(6):401-6.

PMID:
8971629
14.

Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Colina AR, Aumont F, Deslauriers N, Belhumeur P, de Repentigny L.

Infect Immun. 1996 Nov;64(11):4514-9.

16.

Purification and characterization of a new xylanase (xylanase B) produced by Streptomyces lividans 66.

Kluepfel D, Vats-Mehta S, Aumont F, Shareck F, Morosoli R.

Biochem J. 1990 Apr 1;267(1):45-50.

Supplemental Content

Loading ...
Support Center